Biosense Webster (Diamond Bar, California) has received FDA approval for its Thermocool Smarttouch catheter, making it the first therapeutic catheter approved in the U.S. that enables direct and real-time measurement of contact force during catheter ablation procedures for patients suffering from drug-resistant paroxysmal atrial fibrillation (Afib), sustained monomorphic ischemic ventricular tachycardia and Type I atrial flutter. Read More
